Peanut Allergy
Early oral immunotherapy for peanut allergy found safe, ‘highly effective’ in children
Adverse events with early age oral immunotherapy for peanut allergy did not occur in 54% of pediatric patients in a real-world setting, according to a research letter published in Pediatric Allergy and Immunology.
Peanut consumption varies by race, ethnicity
SAN DIEGO — Peanut consumption in the United States varied by race and ethnicity, according to a poster presented at the 2025 American Academy of Allergy, Asthma & Immunology/World Allergy Organization Joint Congress.
Most families reintroduce allergens into diets after negative oral food challenges
SAN DIEGO — Nearly all children with a food allergy who passed an oral food challenge reintroduced the allergen into their diets within the next 4 weeks, according to an abstract presented here.
Exclusively breastfeeding infants for first 4 months may lower risk for food allergy
Exclusively breastfeeding for the first 4 months may reduce the risk for IgE-mediated food allergy among infants, according to study results published in Annals of Allergy, Asthma and Immunology.
Odds for successful peanut oral immunotherapy fall with consecutive missed doses
SAN DIEGO — Odds for desensitization and remission fell as patients missed consecutive doses of peanut oral immunotherapy, according to a poster presented here.
Peanut allergy vaccine deemed safe, tolerable in phase 1 study
SAN DIEGO — A hypoallergenic therapeutic vaccine candidate for peanut allergy was safe and tolerable, according to a poster presented at the 2025 American Academy of Allergy, Asthma & Immunology/World Allergy Organization Joint Congress.
Response to peanut patch treatment increases through 60 months
SAN DIEGO — Percentages of children with peanut allergy who responded to treatment with the VP250 VIASKIN Peanut patch from DBV Technologies increased from 12 months through 60 months, according to an abstract presented here.
Patients introduce allergens into their diets after using omalizumab
SAN DIEGO — Patients with multiple food allergies introduced allergens into their diets after using omalizumab, researchers reported at the 2025 American Academy of Allergy, Asthma & Immunology/World Allergy Organization Joint Congress.
Risks for food allergy increase with mixed diets in first 3 days of infancy
SAN DIEGO — Infants who did not exclusively feed on colostrum during their first 3 days of life were more likely to develop egg or peanut allergy, according to an abstract presented here.
Peanut oral immunotherapy desensitizes children with higher allergy thresholds
Following receipt of increasing peanut oral immunotherapy, or home-measured peanut butter, desensitization to peanut protein in children initially able to ingest more than half a peanut was achieved, according to study results.